Laboratorio Reig Jofre, S.A. (RJF.MC)
EUR 2.91
(0.69%)
EUR 2.91
(0.69%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 10.51 Million EUR | 27.93% |
| 2022 | 9.37 Million EUR | 5.75% |
| 2021 | 8.86 Million EUR | -3.96% |
| 2020 | 9.22 Million EUR | 45.94% |
| 2019 | 6.32 Million EUR | -28.37% |
| 2018 | 8.82 Million EUR | -2.16% |
| 2017 | 9.02 Million EUR | -23.2% |
| 2016 | 11.74 Million EUR | -0.03% |
| 2015 | 11.75 Million EUR | 320.18% |
| 2014 | 2.79 Million EUR | 38.87% |
| 2013 | 2.01 Million EUR | 1473.44% |
| 2012 | 128 Thousand EUR | 100.77% |
| 2011 | -16.67 Million EUR | 12.99% |
| 2010 | -19.16 Million EUR | -30.01% |
| 2009 | -14.74 Million EUR | -210.11% |
| 2008 | 13.38 Million EUR | 201.59% |
| 2007 | -13.17 Million EUR | -375.77% |
| 2006 | 4.77 Million EUR | 166.39% |
| 2005 | 1.79 Million EUR | -43.23% |
| 2004 | 3.15 Million EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 2.94 Million EUR | -14.94% |
| 2024 Q1 | 4.44 Million EUR | 45.67% |
| 2024 Q2 | 3.53 Million EUR | -20.51% |
| 2023 Q1 | 3.27 Million EUR | 0.4% |
| 2023 Q3 | 2.83 Million EUR | -2.04% |
| 2023 FY | 11.99 Million EUR | 27.93% |
| 2023 Q2 | 2.89 Million EUR | -11.61% |
| 2023 Q4 | 3.05 Million EUR | 7.73% |
| 2022 Q4 | 3.25 Million EUR | 135.48% |
| 2022 FY | 9.37 Million EUR | 5.75% |
| 2022 Q3 | 1.38 Million EUR | 0.0% |
| 2021 Q3 | 2.09 Million EUR | 1152.69% |
| 2021 Q2 | 167 Thousand EUR | -96.29% |
| 2021 Q1 | 4.5 Million EUR | 78.82% |
| 2021 FY | 8.86 Million EUR | -3.96% |
| 2021 Q4 | 2.1 Million EUR | 0.53% |
| 2020 Q3 | 1.86 Million EUR | 126.52% |
| 2020 FY | 9.22 Million EUR | 45.94% |
| 2020 Q1 | 4.02 Million EUR | 38.29% |
| 2020 Q2 | 822 Thousand EUR | -79.59% |
| 2020 Q4 | 2.51 Million EUR | 35.18% |
| 2019 Q1 | 3.08 Million EUR | -7.61% |
| 2019 FY | 6.32 Million EUR | -28.37% |
| 2019 Q4 | 2.91 Million EUR | 518.39% |
| 2019 Q3 | -696 Thousand EUR | -168.3% |
| 2019 Q2 | 1.01 Million EUR | -67.0% |
| 2018 FY | 8.82 Million EUR | -2.16% |
| 2018 Q1 | 2.81 Million EUR | -39.87% |
| 2018 Q4 | 3.34 Million EUR | 108.78% |
| 2018 Q3 | 1.6 Million EUR | 49.83% |
| 2018 Q2 | 1.06 Million EUR | -62.07% |
| 2017 FY | 9.02 Million EUR | -23.2% |
| 2017 Q4 | 4.68 Million EUR | 572.94% |
| 2017 Q3 | 696.14 Thousand EUR | -29.21% |
| 2017 Q2 | 983.34 Thousand EUR | -63.13% |
| 2017 Q1 | 2.66 Million EUR | -42.11% |
| 2016 Q3 | 2.43 Million EUR | 24.57% |
| 2016 Q4 | 4.6 Million EUR | 89.18% |
| 2016 FY | 11.74 Million EUR | -0.03% |
| 2016 Q1 | 2.75 Million EUR | 62.94% |
| 2016 Q2 | 1.95 Million EUR | -28.93% |
| 2015 FY | 11.75 Million EUR | 320.18% |
| 2015 Q2 | 1.73 Million EUR | -73.72% |
| 2015 Q3 | 1.73 Million EUR | 0.14% |
| 2015 Q4 | 1.68 Million EUR | -2.73% |
| 2015 Q1 | 6.59 Million EUR | 1437.86% |
| 2014 Q1 | 2.49 Million EUR | 352.89% |
| 2014 FY | 2.79 Million EUR | 38.87% |
| 2014 Q4 | 428.82 Thousand EUR | -35.12% |
| 2014 Q3 | 661 Thousand EUR | 183.78% |
| 2014 Q2 | -789 Thousand EUR | -131.61% |
| 2013 Q3 | 732 Thousand EUR | 234.56% |
| 2013 Q4 | -987 Thousand EUR | -234.84% |
| 2013 FY | 2.01 Million EUR | 1473.44% |
| 2013 Q1 | 2.81 Million EUR | 571.98% |
| 2013 Q2 | -544 Thousand EUR | -119.34% |
| 2012 Q1 | 1.62 Million EUR | 110.71% |
| 2012 Q2 | -897 Thousand EUR | -155.34% |
| 2012 Q3 | 563 Thousand EUR | 162.76% |
| 2012 Q4 | -596 Thousand EUR | -205.86% |
| 2012 FY | 128 Thousand EUR | 100.77% |
| 2011 Q1 | 867 Thousand EUR | 0.0% |
| 2011 Q4 | -15.13 Million EUR | 0.0% |
| 2011 FY | -16.67 Million EUR | 12.99% |
| 2011 Q2 | -2.4 Million EUR | -377.62% |
| 2010 Q1 | 1.52 Million EUR | 0.0% |
| 2010 Q2 | -1.11 Million EUR | -173.13% |
| 2010 FY | -19.16 Million EUR | -30.01% |
| 2009 Q1 | 3.12 Million EUR | 0.0% |
| 2009 FY | -14.74 Million EUR | -210.11% |
| 2008 FY | 13.38 Million EUR | 201.59% |
| 2007 FY | -13.17 Million EUR | -375.77% |
| 2006 FY | 4.77 Million EUR | 166.39% |
| 2005 FY | 1.79 Million EUR | -43.23% |
| 2004 FY | 3.15 Million EUR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Almirall, S.A. | -5.26 Million EUR | 299.658% |
| Faes Farma, S.A. | 185.28 Million EUR | 94.328% |